We’re committed to building an equitable health care system. To do that, it’s important to build trust, partner with communities and address barriers that stand between patients and their medicines. These themes came up at several events PhRMA participated in last month in Washington, D.C.
The Congressional Black Caucus Foundation’s Annual Legislative Conference (CBCF ALC)
U.S. Representative Jasmine Crockett (TX-30) opened the panel by highlighting innovation and collaboration in addressing clinical trial diversity. The discussion, moderated by Anthony Coley, founding partner of Corner Office Strategies, featured:
- Tesheia Johnson Harris, senior advisor and network partner leader for Equitable Breakthroughs in Medicine Development (EQBMED)
- Reverend Dr. Leroy O. Perry, Jr., trusted messenger for EQBMED
- Dr. Darryl Sleep, head of global public health at Amgen
The Congressional Hispanic Caucus Institute’s (CHCI) Leadership Conference
PhRMA’s Chief Medical Officer Dr. Michael Ybarra and Amy Hinojosa, president and CEO of MANA, A National Latina Organization, discussed barriers Hispanic patients face in accessing care. They explored policy solutions to support health equity, such as regulating insurers and PBMs and ensuring the 340B program benefits intended communities.
These discussions mirror actions we’re taking as an industry to address misinformation, enhance access to innovative clinical trials, tackle harmful practices by middlemen and ensure the 340B program serves its purpose. Together, we can advance health equity and improve patients’ lives.
To learn more about PhRMA’s Equity Initiative, visit: PhRMA.org/Equity.
Stephen J. Ubl
Stephen J. Ubl is president and chief executive officer of the Pharmaceutical Research and Manufacturers of America (PhRMA), which represents America’s leading biopharmaceutical research companies. The U.S. biopharmaceutical sector directly employs more than 800,000 Americans and invests more than $100 billion in research and development annually – more than any other industry in America.
Ubl leads PhRMA’s work preserving and strengthening a health care and economic environment that encourages medical innovation, new drug discovery and access to life-saving medicines. Ubl is recognized around the world as a leading health care advocate and policy expert who collaborates successfully with diverse stakeholder groups – including patient and physician groups, regulators, public and private payers, and global trade organizations – to help ensure timely patient access to innovative treatments and cures. The New York Times writes, “If anyone can find areas of agreement with the critics, or at least work productively with them, it may be Mr. Ubl. He is more conversant with the intricacies of health policy, and more adept at the politics."
Previously, Ubl served as president and CEO of medical technology association AdvaMed, where he helped facilitate landmark reforms related to the U.S. Food and Drug Administration product review process and Medicare’s coverage and reimbursement of medical technologies. He led the industry’s defense of breakthrough R&D, successfully delaying an innovation-stifling device tax, and, in 2013, was recognized by a leading industry publication as one of 10 people to have a lasting impact on the medical technology industry.
Ubl has worked extensively with patient advocacy organizations in health policy, including longstanding service on the board of the National Health Council, a leading umbrella organization for voluntary health care organizations and has been personally involved with JDRF (formerly known as the Juvenile Diabetes Research Foundation).
He is routinely recognized as one of Washington’s most effective advocates. Ubl has been recognized on Business Insider’s “DC Healthcare Power Players” and Modern Healthcare’s “100 Most Influential People in Healthcare.” He is identified as a top health influencer by Medical Marketing & Media and PR Week magazines.
https://www.linkedin.com/in/steveubl/
President and Chief Executive Officer
ICYMI: PhRMA’s 4th Annual Pathways to Success: Virtual STEM Career Expo
Hispanic Heritage Month: Fighting for Hispanic patients
PhRMA awards grants to 2024 Annual Pathways to Success: Virtual STEM Career Expo Partners
How government price setting fails to address systemic health care inequities
Recent events highlight progress on health equity
Health Equity
Recent events highlight progress on health equity
Recent events highlight progress on health equity